Episodic neurologic disorders: Syndromes, genes, and mechanisms

Annual Review of Neuroscience

Volumn 36, Issue , 2013, Pages 25-50

  Russell, Jonathan F ^a   Fu, Ying Hui ^a   Ptáček, Louis J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Channelopathy; Exome sequencing; Mendelian; Neurogenetics; Paroxysmal; Synaptopathy

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ATRIAL NATRIURETIC FACTOR; GAP JUNCTION PROTEIN; NUCLEOPORIN; POTASSIUM; POTASSIUM CHANNEL; VOLTAGE GATED CALCIUM CHANNEL;

ANDERSEN SYNDROME; ANTICOAGULATION; BECKER MUSCULAR DYSTROPHY; BRAIN ARTERY; BRUGADA SYNDROME; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; CHANNELOPATHY; CONGENITAL ANALGESIA; CONGENITAL MYASTHENIC SYNDROME; CORTICAL DYSPLASIA; DEMENTIA; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DOPAMINE RELEASE; DYSKINESIA; ENVIRONMENTAL FACTOR; EPILEPSY; FAINTNESS; FAMILIAL HEMIPLEGIC MIGRAINE; GENE MUTATION; GENERALIZED EPILEPSY; GENETIC RISK; GENETICS; GENOTYPE PHENOTYPE CORRELATION; HEART OUTPUT; HEART REPOLARIZATION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HEMIPLEGIC MIGRAINE; HUMAN; HYPOKALEMIC PERIODIC PARALYSIS; INTRACTABLE EPILEPSY; JERVELL AND LANGE-NIELSEN SYNDROME; KETOGENIC DIET; LONG QT SYNDROME; MIGRAINE; MISSENSE MUTATION; MULTIFACTORIAL INHERITANCE; MYASTHENIA GRAVIS; MYOCLONUS; MYOCLONUS DYSTONIA; MYOCLONUS EPILEPSY; NEUROLOGIC DISEASE; NEUROMUSCULAR TRANSMISSION; NONHUMAN; ORTHOSTATIC HYPOTENSION; PAROXYSMAL KINESIGENIC DYSKINESIA; PERIODIC PARALYSIS; PHENOTYPE; PHONOPHOBIA; PHOTOPHOBIA; POSTSYNAPTIC MEMBRANE; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; QT INTERVAL; REVIEW; SEVERE MYOCLONIC EPILEPSY IN INFANCY; SHORT QT SYNDROME; SLEEP DISORDER; SODIUM CURRENT; SPREADING CORTICAL DEPRESSION; STIFF MAN SYNDROME; SUDDEN CARDIAC DEATH; TEMPORAL LOBE EPILEPSY; THOMSEN DISEASE; TORSADE DES POINTES; TRANSIENT ISCHEMIC ATTACK;

AFFECTIVE SYMPTOMS; ANIMALS; CENTRAL NERVOUS SYSTEM; CHANNELOPATHIES; HUMANS; MUSCLE, SKELETAL; MUTATION; NERVOUS SYSTEM DISEASES; NEUROMUSCULAR JUNCTION; PERIPHERAL NERVES;

EID: 84880318442     PISSN: 0147006X     EISSN: 15454126     Source Type: Book Series    
DOI: 10.1146/annurev-neuro-062012-170300     Document Type: Review

References (160)

1. Andrade DM. 2009. Genetic basis in epilepsies caused by malformations of cortical development and in those with structurally normal brain. Hum. Genet. 126:173-933
2. Andres-Enguix I, Shang L, Stansfeld PJ, Morahan JM, Sansom MSP, et al. 2012. Functional analysis of missense variants in the TRESK (KCNK18) K+ channel. Sci. Rep. 2:2377
3. Badhwar A, Berkovic S, Dowling JP, Gonzales M, Narayanan S, et al. 2004. Action myoclonus-renal failure syndrome: characterisation of a unique cerebro-renal disorder. Brain 127:2173-822
4. Bamshad MJ, Ng SB, Bigham AW, Tabor HK, Emond MJ, et al. 2011. Exome sequencing as a tool for Mendelian disease gene discovery. Nat. Rev. Genet. 12:745-555
5. Barišić N, Chaouch A, Müller JS, Lochmüller H. 2011. Genetic heterogeneity and pathophysiological mechanisms in congenital myasthenic syndromes. Eur. J. Paediatr. Neurol. 15:189-966
6. Barkovich AJ, Guerrini R, Kuzniecky RI, Jackson GD, Dobyns WB. 2012. A developmental and genetic classification for malformations of cortical development: update 2012. Brain 135:1348-699
7. Baulac S, Huberfeld G, Gourfinkel-An I, Mitropoulou G, Beranger A, et al. 2001. First genetic evidence of GABA(A) receptor dysfunction in epilepsy: amutation in the gamma2-subunit gene. Nat. Genet. 28:46-488
8. Benoit G, Machuca E, Heidet L, Antignac C. 2010. Hereditary kidney diseases: highlighting the importance of classical Mendelian phenotypes. Ann. N. Y. Acad. Sci. 1214:83-933
9. Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, et al. 2010. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 51:676-855
10. Berg AT, Scheffer IE. 2011. New concepts in classification of the epilepsies: entering the 21st century. Epilepsia 52:1058-622
11. Bhatia KP. 2011. Paroxysmal dyskinesias. Mov. Disord. 26:1157-655
12. Bockenhauer D, Feather S, Stanescu HC, Bandulik S, Zdebik AA, et al. 2009. Epilepsy, ataxia, sensorineural deafness, tubulopathy, and KCNJ10 mutations. N. Engl. J. Med. 360:1960-700
13. Brennan KC, Bates EA, Shapiro RE, Zyuzin J, Hallows WC, et al. 2013. Casein kinase iδ mutations in familial migraine and advanced sleep phase. Sci. Transl. Med. 5:183ra56
14. Bruno MK, Hallett M, Gwinn-Hardy K, Sorensen B, Considine E, et al. 2004. Clinical evaluation of idiopathic paroxysmal kinesigenic dyskinesia: new diagnostic criteria. Neurology 63:2280-877
15. Bulman DE, Scoggan KA, van Oene MD, Nicolle MW, Hahn AF, et al. 1999. A novel sodium channel mutation in a family with hypokalemic periodic paralysis. Neurology 53:1932-366
16. Caviness J, Brown P. 2004. Myoclonus: current concepts and recent advances. Lancet Neurol. 3:598-6077
17. Chen L, Marquardt ML, Tester DJ, Sampson KJ, Ackerman MJ, Kass RS. 2007. Mutation of an A-kinaseanchoring protein causes long-QT syndrome. Proc. Natl. Acad. Sci. USA 104:20990-955
18. Chen WJ, Lin Y, Xiong ZQ, Wei W, Ni W, et al. 2011. Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia. Nat. Genet. 43:1252-555
19. Cheng CJ, Lin SH, Lo YF, Yang SS, Hsu YJ, et al. 2011. Identification and functional characterization ofKir2. 66 mutations associated with non-familial hypokalemic periodic paralysis. J. Biol. Chem. 286:27425-355
20. Choi M, Scholl UI, Ji W, Liu T, Tikhonova IR, et al. 2009. Genetic diagnosis by whole exome capture and massively parallel DNA sequencing. Proc. Natl. Acad. Sci. USA 106:19096-1011
21. Clare JJ. 2010. Targeting voltage-gated sodium channels for pain therapy. Expert Opin. Investig. Drugs 19:45-622
22. Cloarec R, Bruneau N, Rudolf G, Massacrier A, Salmi M, et al. 2012. PRRT2 links infantile convulsions and paroxysmal dyskinesia with migraine. Neurology 79:2097-1033
23. Corbett MA, Bahlo M, Jolly L, Afawi Z, Gardner AE, et al. 2010. A focal epilepsy and intellectual disability syndrome is due to a mutation in TBC1D24. Am. J. Hum. Genet. 87:371-755
24. Cox JJ, Reimann F, Nicholas AK, Thornton G, Roberts E, et al. 2006. An SCN9A channelopathy causes congenital inability to experience pain. Nature 444:894-988
25. de Carvalho Aguiar P, Sweadner KJ, Penniston JT, Zaremba J, Liu L, et al. 2004. Mutations in the Na+/K+-ATPase alpha3 gene ATP1A3 are associated with rapid-onset dystonia parkinsonism. Neuron 43:169-755
26. De Fusco M, Marconi R, Silvestri L, Atorino L, Rampoldi L, et al. 2003. Haploinsufficiency of ATP1A22 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat. Genet. 33:192-966
27. de Nijs L, Léon C, Nguyen L, Loturco JJ, Delgado-Escueta AV, et al. 2009. EFHC1 interacts with microtubules to regulate cell division and cortical development. Nat. Neurosci. 12:1266-744
28. DeVivo DC, Trifiletti RR, Jacobson RI, Ronen GM, Behmand RA, Harik SI. 1991. Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. N. Engl. J. Med. 325:703-99
29. Della-Morte D, Guadagni F, Palmirotta R, Testa G, Caso V, et al. 2012. Genetics of ischemic stroke, strokerelated risk factors, stroke precursors and treatments. Pharmacogenomics 13:595-6133
30. Depienne C, Bouteiller D, Keren B, Cheuret E, Poirier K, et al. 2009. Sporadic infantile epileptic encephalopathy caused by mutations in PCDH19 resembles Dravet syndrome but mainly affects females. PLoS Genet. 5:e10003811
31. Depienne C, Trouillard O, Bouteiller D, Gourfinkel-An I, Poirier K, et al. 2011. Mutations and deletions in PCDH19 account for various familial or isolated epilepsies in females. Hum. Mutat. 32:E1959-755
32. Dibbens LM, Feng HJ, Richards MC, Harkin LA, Hodgson BL, et al. 2004. GABRD encoding a protein for extra- or peri-synaptic GABAA receptors is a susceptibility locus for generalized epilepsies. Hum. Mol. Genet. 13:1315-199
33. Dichgans M, Freilinger T, Eckstein G, Babini E, Lorenz-Depiereux B, et al. 2005. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 366:371-777
34. Dodick DW. 2008. Examining the essence of migraine - is it the blood vessel or the brain? A debate. Headache 48:661-677
35. Donath S, Li P, Willenbockel C, Al-Saadi N, Gross V, et al. 2006. Apoptosis repressorwith caspase recruitment domain is required for cardioprotection in response to biomechanical and ischemic stress. Circulation 113:1203-122
36. Dreissen YEM, Bakker MJ, Koelman JHTM, Tijssen MAJ. 2012. Exaggerated startle reactions. Clin. Neurophysiol. 123:34-444
37. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, et al. 2006. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314:1461-633
38. Eichler EE, Flint J, Gibson G, Kong A, Leal SM, et al. 2010. Missing heritability and strategies for finding the underlying causes of complex disease. Nat. Rev. Genet. 11:446-500
39. Eriksen MK, Thomsen LL, Andersen I, Nazim F, Olesen J. 2004. Clinical characteristics of 362 patients with familial migraine with aura. Cephalalgia 24:564-755
40. Escayg A, MacDonald BT, Meisler MH, Baulac S, Huberfeld G, et al. 2000. Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+. Nat. Genet. 24:343-455
41. Estacion M, Gasser A, Dib-Hajj SD, Waxman SG. 2010. A sodium channel mutation linked to epilepsy increases ramp and persistent current of Nav1. 3 and induces hyperexcitability in hippocampal neurons. Exp. Neurol. 224:362-688
42. Fahn S. 2011. Classification of movement disorders. Mov. Disord. 26:947-577
43. Falace A, Filipello F, La Padula V, Vanni N, Madia F, et al. 2010. TBC1D24, an ARF6-interacting protein, is mutated in familial infantile myoclonic epilepsy. Am. J. Hum. Genet. 87:365-700
44. Fertleman CR, Baker MD, Parker KA, Moffatt S, Elmslie FV, et al. 2006. SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes. Neuron 52: 767-744
45. Gardiner AR, Bhatia KP, Stamelou M, Dale RC, Kurian MA, et al. 2012. PRRT2 gene mutations: from paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine. Neurology 79:2115-211
46. Gauer RL. 2011. Evaluation of syncope. Am. Fam. Phys. 84:640-500
47. Geis C, Weishaupt A, Hallermann S, Gr ünewald B, Wessig C, et al. 2010. Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic inhibition. Brain 133:3166-800
48. Ghezzi D, Viscomi C, Ferlini A, Gualandi F, Mereghetti P, et al. 2009. Paroxysmal nonkinesigenic dyskinesia is caused by mutations of the MR-1 mitochondrial targeting sequence. Hum. Mol. Genet. 18:1058-644
49. Gillis J, Pavlidis P. 2012. "Guilt by association" is the exception rather than the rule in gene networks. PLoS Comput. Biol. 8:e10024444
50. Goldstein JL, Brown MS. 2009. The LDL receptor. Arterioscler. Thromb. Vasc. Biol. 29:431-388
51. Gonzaga-Jauregui C, Lupski JR, Gibbs RA. 2012. Human genome sequencing in health and disease. Annu. Rev. Med. 63:35-611
52. Grabrucker AM, Schmeisser MJ, Schoen M, Boeckers TM. 2011. Postsynaptic ProSAP/Shank scaffolds in the cross-hair of synaptopathies. Trends Cell Biol. 21:594-6033
53. Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, et al. 2005. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc. Natl. Acad. Sci. USA 102:7227-322
54. Haut SR, Bigal ME, Lipton RB. 2006. Chronic disorders with episodic manifestations: focus on epilepsy and migraine. Lancet Neurol. 5:148-577
55. Heinzen EL, Swoboda KJ, Hitomi Y, Gurrieri F, Nicole S, et al. 2012. De novo mutations in ATP1A3 cause alternating hemiplegia of childhood. Nat. Genet. 44:1030-344
56. Helbig I, Scheffer IE, Mulley JC, Berkovic SF. 2008. Navigating the channels and beyond: unraveling the genetics of the epilepsies. Lancet Neurol. 7:231-455
57. Heron SE, Grinton BE, Kivity S, Afawi Z, Zuberi SM, et al. 2012. PRRT2 mutations cause benign familial infantile epilepsy and infantile convulsions with choreoathetosis syndrome. Am. J. Hum. Genet. 90:152-600
58. Higuchi O, Hamuro J, Motomura M, Yamanashi Y. 2011. Autoantibodies to low-density lipoprotein receptorrelated protein 4 in myasthenia gravis. Ann. Neurol. 69:418-222
59. Hoch W, McConville J, Helms S, Newson-Davis J, Melms A, Vincent A. 2001. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat. Med. 7:365-688
60. Hoffmann K, Muller JS, Stricker S, Megarbane A, Rajab A, et al. 2006. Escobar syndrome is a prenatal myasthenia caused by disruption of the acetylcholine receptor fetal gamma subunit. Am. J. Hum. Genet. 79:303-122
61. Holland KD, Kearney JA, Glauser TA, Buck G, Keddache M, et al. 2008. Mutation of sodium channel SCN3A in a patient with cryptogenic pediatric partial epilepsy. Neurosci. Lett. 433:65-700
62. Irani SR, Pettingill P, Kleopa KA, Schiza N, Waters P, et al. 2012. Morvan syndrome: clinical and serological observations in 29 cases. Ann. Neurol. 72:241-555
63. Jen JC. 2008. Hereditary episodic ataxias. Ann. N. Y. Acad. Sci. 1142:250-533
64. Jen JC, Graves TD, Hess EJ, Hanna MG, Griggs RC, et al. 2007. Primary episodic ataxias: diagnosis, pathogenesis and treatment. Brain 130:2484-933
65. Jen JC, Wan J, Palos TP, Howard BD, Baloh RW. 2005. Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures. Neurology 65:529-344
66. Jurkat-Rott K, Lerche H, Weber Y, Lehmann-Horn F. 2010. Hereditary channelopathies in neurology. Adv. Exp. Med. Biol. 686:305-344
67. Kalachikov S, Evgrafov O, Ross B, Winawer M, Barker-Cummings C, et al. 2002. Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features. Nat. Genet. 30:335-411
68. Kitamura K, Yanazawa M, Sugiyama N, Miura H, Iizuka-Kogo A, et al. 2002. Mutation of ARX causes abnormal development of forebrain and tests in mice and X-linked lissencephaly with abnormal genitalia in humans. Nat. Genet. 32:359-699
69. Klassen T, Davis C, Goldman A, Burgess D, Chen T, et al. 2011. Exome sequencing of ion channel genes reveals complex profiles confounding personal risk assessment in epilepsy. Cell 145:1036-488
70. Kleopa KA. 2011. Autoimmune channelopathies of the nervous system. Curr. Neuropharmacol. 9:458-677
71. Koch MC, Steinmeyer K, Lorenz C, Ricker K, Wolf F, et al. 1992. The skeletal muscle chloride channel in dominant and recessive human myotonia. Science 257:797-8000
72. Koseki T, Inohara N, Chen S, Núñez G. 1998. ARC, an inhibitor of apoptosis expressed in skeletal muscle and heart that interacts selectively with caspases. Proc. Natl. Acad. Sci. USA 95:5156-600
73. Kullmann DM. 2010. Neurological channelopathies. Annu. Rev. Neurosci. 33:151-722
74. Lafrenière RG, Zameel Cader M, Poulin J-F, Andres-Enguix I, Simoneau M, et al. 2010. A dominant-negative mutation in the TRESK potassium channel is linked to familial migraine with aura. Nat. Med. 16:1157-600
75. Lai M, Huijbers MG, Lancaster E, Graus F, Bataller L, et al. 2010. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol. 9:776-855
76. Lancaster E, Huijbers MG, Bar V, Boronat A, Wong A, et al. 2011. Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia. Ann. Neurol. 69:303-111
77. Lee HY, Huang Y, Bruneau N, Roll P, Roberson EDO, et al. 2012a. Mutations in the novel protein PRRT22 cause paroxysmal kinesigenic dyskinesia with infantile convulsions. Cell Rep. 1:2-122
78. Lee HY, Nakayama J, Xu Y, Fan X, Karouani M, et al. 2012b. Dopamine dysregulation in a mouse model of paroxysmal nonkinesigenic dyskinesia. J. Clin. Investig. 122:507-188
79. Lee HY, Xu Y, Huang Y, Ahn AH, Auburger GW, et al. 2004. The gene for paroxysmal nonkinesigenic dyskinesia encodes an enzyme in a stress response pathway. Hum. Mol. Genet. 13:3161-700
80. Leen WG, Klepper J, Verbeek MM, Leferink M, Hofste T, et al. 2010. Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder. Brain 133:655-700
81. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. 2005. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J. Exp. Med. 202:473-777
82. Leo L, Gherardini L, Barone V, De Fusco M, Pietrobon D, et al. 2011. Increased susceptibility to cortical spreading depression in the mouse model of familial hemiplegic migraine type 2. PLoS Genet. 7:e10021299
83. Li J, Zhu X, Wang X, Sun W, Feng B, et al. 2012. Targeted genomic sequencing identifies PRRT2 mutations as a cause of paroxysmal kinesigenic choreoathetosis. J. Med. Genet. 49:76-788
84. Lossin C, George AL Jr. 2008. Myotonia congenita. Adv. Genet. 63:25-555
85. Loukaides P, Schiza N, Pettingill P, Palazis L, Vounou E, et al. 2012. Morvan's syndrome associated with antibodies to multiple components of the voltage-gated potassium channel complex. J. Neurol. Sci. 312:52-566
86. Mahida S, Lubitz SA, Rienstra M, Milan DJ, Ellinor PT. 2011. Monogenic atrial fibrillation as pathophysiological paradigms. Cardiovasc. Res. 89:692-7000
87. Mantegazza M, Rusconi R, Scalmani P, Avanzini G, Franceschetti S. 2010. Epileptogenic ion channel mutations: from bedside to bench and, hopefully, back again. Epilepsy Res. 92:1-299
88. Marini C, Conti V, Mei D, Battaglia D, Lettori D, et al. 2012. PRRT2 mutations in familial infantile seizures, paroxysmal dyskinesia, and hemiplegic migraine. Neurology 79:2109-144
89. Martin MS, Dutt K, Papale LA, Dubé CM, Dutton SB, et al. 2010. Altered function of the SCN1A voltagegated sodium channel leads to gamma-aminobutyric acid-ergic (GABAergic) interneuron abnormalities. J. Biol. Chem. 285:9823-344
90. Maselli RA, Ng JJ, Anderson JA, Cagney O, Arredondo J, et al. 2009. Mutations in LAMB2 causing a severe form of synaptic congenital myasthenic syndrome. J. Med. Genet. 46:203-88
91. McBride KL, Garg V. 2010. Impact of Mendelian inheritance in cardiovascular disease. Ann. N. Y. Acad. Sci. 1214:122-377
92. McClatchey AI, McKenna-Yasek D, Cros D, Worthen HG, Kuncl RW, et al. 1992. Novel mutations in families with unusual and variable disorders of the skeletal muscle sodium channel. Nat. Genet. 2:148-522
93. Mihaylova V, Muller JS, Vilchez JJ, Salih MA, Kabiraj MM, et al. 2008. Clinical andmolecular genetic findings in COLQ-mutant congenital myasthenic syndromes. Brain 131:747-599
94. Mohler PJ, Schott JJ, Gramolini AO, Dilly KW, Guatimosim S, et al. 2003. Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature 421:634-399
95. Morar B, Zhelyazkova S, Azmanov DN, Radionova M, Angelicheva D, et al. 2011. A novel GEFS+ locus on 12p13. 33 in a large Roma family. Epilepsy Res. 97:198-2077
96. Morishita H, Yagi T. 2007. Protocadherin family: diversity, structure, and function. Curr. Opin. Cell Biol. 19:584-922
97. Nam YJ, Mani K, Ashton AW, Peng CF, Krishnamurthy B, et al. 2004. Inhibition of both the extrinsic and intrinsic death pathways through nonhomotypic death-fold interactions. Mol. Cell 15:901-122
98. Nardocci N, Zorzi G, Barzaghi C, Zibordi F, Ciano C, et al. 2008. Myoclonus-dystonia syndrome: clinical presentation, disease course, and genetic features in 11 families. Mov. Disord. 23:28-344
99. Neville BG, Ninan M. 2007. The treatment and management of alternating hemiplegia of childhood. Dev. Med. Child Neurol. 49:777-800
100. Nicita F, De Liso P, Danti FR, Papetti L, Ursitti F, et al. 2012. The genetics of monogenic idiopathic epilepsies and epileptic encephalopathies. Seizure 21:3-111
101. Nyegaard M, Overgaard MT, Sondergaard MT, Vranas M, Behr ER, et al. 2012. Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death. Am. J. Hum. Genet. 91:703-122
102. O'Roak BJ, Vives L, Girirajan S, Karakoc E, Krumm N, et al. 2012. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 485:246-500
103. Pevzner A, Schoser B, Peters K, Cosma NC, Karakatsani A, et al. 2012. Anti-LRP4 autoantibodies in AChRand MuSK-antibody-negative myasthenia gravis. J. Neurol. 259:427-355
104. Plaster NM, Tawil R, Tristani-Firouzi M, Canun S, Bendahhou S, et al. 2001. Mutations in Kir2. 1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell 105:511-199
105. Poduri A, Lowenstein D. 2011. Epilepsy genetics - past, present, and future. Curr. Opin. Genet. Dev. 21:325-322
106. Ptaček LJ, George AL Jr, Barchi RL, Griggs RC, Riggs JE, et al. 1992. Mutations in an S4 segment of the adult skeletal muscle sodium channel cause paramyotonia congenita. Neuron 8:891-977
107. Ptícek LJ, George AL Jr, Griggs RC, Tawil R, Kallen RG, et al. 1991. Identification of a mutation in the gene causing hyperkalemic periodic paralysis. Cell 67:1021-277
108. Ptaček LJ, Tawil R, Griggs RC, Engel AG, Layzer RB, et al. 1994a. Dihydropyridine receptor mutations cause hypokalemic periodic paralysis. Cell 77:863-688
109. Ptaček LJ, Tawil R, Griggs RC, Meola G, McManis P, et al. 1994b. Sodium channel mutations in acetazolamide-responsive myotonia congenita, paramyotonia congenita, and hyperkalemic periodic paralysis. Neurology 44:1500-33
110. Rainier S, Thomas D, Tokarz D, Ming L, Bui M, et al. 2004. Myofibrillogenesis regulator 1 gene mutations cause paroxysmal dystonic choreoathetosis. Arch. Neurol. 61:1025-299
111. Raja Rayan DL, Hanna MG. 2010. Skeletal muscle channelopathies: nondystrophic myotonias and periodic paralysis. Curr. Opin. Neurol. 23:466-766
112. Ramachandran N, Girard JM, Turnbull J, Minassian BA. 2009. The autosomal recessively inherited progressive myoclonus epilepsies and their genes. Epilepsia 50(Suppl. 5):29-366
113. Rees MI, Harvey K, Pearce BR, Chung SK, Duguid IC, et al. 2006. Mutations in the gene encoding GlyT22 (SLC6A5) define a presynaptic component of human startle disease. Nat. Genet. 38:801-66
114. Rojas CV, Wang JZ, Schwartz LS, Hoffman EP, Powell BR, Brown RH Jr. 1991. A Met-to-Val mutation in the skeletal muscle Na+ channel alpha-subunit in hyperkalaemic periodic paralysis. Nature 354:387-899
115. Roux-Buisson N, Cacheux M, Fourest-Lieuvin A, Fauconnier J, Brocard J, et al. 2012. Absence of triadin, a protein of the calcium release complex, is responsible for cardiac arrhythmia with sudden death in humans. Hum. Mol. Genet. 21:2759-677
116. Roze E, Apartis E, Clot F, Dorison N, Thobois S, et al. 2008. Myoclonus-dystonia: clinical and electrophysiologic pattern related to SGCE mutations. Neurology 70:1010-166
117. Russell JF, Steckley JL, Coppola G, Hahn AFG, Howard MA, et al. 2012. Familial cortical myoclonus with a mutation in NOL3. Ann. Neurol. 72:175-833
118. Ryan DP, da Silva MR, Soong TW, Fontaine B, Donaldson MR, et al. 2010. Mutations in potassium channel Kir2. 6 cause susceptibility to thyrotoxic hypokalemic periodic paralysis. Cell 140:88-988
119. Ryan DP, Ptícek LJ. 2010. Episodic neurological channelopathies. Neuron 68:282-922
120. Saitsu H, Kato M, Mizuguchi T, Hamada K, Osaka H, et al. 2008. De novo mutations in the gene encoding STXBP1 (MUNC18-1) cause early infantile epileptic encephalopathy. Nat. Genet. 40:782-888
121. Sanders J, Murtha MT, Gupta AR, Murdoch JD, Raubeson MJ, et al. 2012. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 485:237-411
122. Scholl UI, Choi M, Liu T, Ramaekers VT, Hüsler MG, et al. 2009. Seizures, sensorineural deafness, ataxia, mental retardation, and electrolyte imbalance (SeSAME syndrome) caused by mutations in KCNJ10. Proc. Natl. Acad. Sci. USA 106:5842-477
123. Sehgal A, Mignot E. 2011. Genetics of sleep and sleep disorders. Cell 146:194-2077
124. Seidner G, Alvarez MG, Yeh JI, O'Driscoll KR, Klepper J, et al. 1998. GLUT-1 deficiency syndrome caused by haploinsufficiency of the blood-brain barrier hexose carrier. Nat. Genet. 18:188-911
125. Sheffield VC, Stone EM. 2011. Genomics and the eye. N. Engl. J. Med. 364:1932-422
126. Shen Y, Lee HY, Rawson J, Ojha S, Babbitt P, et al. 2011. Mutations in PNKD causing paroxysmal dyskinesia alters protein cleavage and stability. Hum. Mol. Genet. 20:2322-322
127. Shiang R, Ryan SG, Zhu YZ, Hahn AF, O'Connell P, Wasmuth JJ. 1993. Mutations in the alpha 1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia. Nat. Genet. 5:351-588
128. Shoubridge C, Fullston T, Gécz J. 2010. ARX spectrum disorders: making inroads into the molecular pathology. Hum. Mutat. 31:889-9000
129. Shyti R, de Vries B, van den Maagdenberg A. 2011. Migraine genes and the relation to gender. Headache 51:880-900
130. Smith SE, Xu L, Kasten MR, Anderson MP. 2012. Mutant LGI1 inhibits seizure-induced trafficking of Kv4. 22 potassium channels. J. Neurochem. 120:611-211
131. Solimena M, Folli F, Denis-Donini S, Comi GC, Pozza G, et al. 1988. Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus. N. Engl. J. Med. 318:1012-200
132. Stafstrom CE. 2009. Severe epilepsy syndromes of early childhood: the link between genetics and pathophysiology with a focus on SCN1A mutations. J. Child Neurol. 24:S15-233
133. Strømme P, Mangelsdorf ME, Shaw MA, Lower KM, Lewis SM, et al. 2002. Mutations in the human ortholog of Aristaless cause X-linked mental retardation and epilepsy. Nat. Genet. 30:441-455
134. Sugawara T, Tsurubuchi Y, Agarwala KL, Ito M, Fukuma G, et al. 2001. A missense mutation of the Na+ channel alpha II subunit gene Na(v)1. 2 in a patient with febrile and afebrile seizures causes channel dysfunction. Proc. Natl. Acad. Sci. USA 98:6384-899
135. Suls A, Dedeken P, Goffin K, Van Esch H, Dupont P, et al. 2008. Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1. Brain 131:1831-444
136. Suzuki T, Delgado-Escueta AV, Aguan K, Alonso ME, Shi J, et al. 2004. Mutations in EFHC1 cause juvenile myoclonic epilepsy. Nat. Genet. 36:842-499
137. Tawil R, McDermott MP, Brown R Jr, Shapiro BC, Ptícek LJ, et al. 2000. Randomized trials of dichlorphenamide in the periodic paralyses. Working Group on Periodic Paralysis. Ann. Neurol. 47:46-533
138. Tennessen JA, Bigham AW, O'Connor TD, Fu W, Kenny EE, et al. 2012. Evolution and functional impact of rare coding variation from deep sequencing of human exomes. Science 337:64-699
139. Tomlinson SE, Hanna MG, Kullmann DM, Tan SV, Burke D. 2009. Clinical neurophysiology of the episodic ataxias: insights into ion channel dysfunction in vivo. Clin. Neurophysiol. 120:1768-766
140. Tottene A, Conti R, Fabbro A, Vecchia D, Shapovalova M, et al. 2009. Enhanced excitatory transmission at cortical synapses as the basis for facilitated spreading depression in Ca(v)2. 1 knockin migraine mice. Neuron 61:762-733
141. Tristani-Firouzi M, Etheridge SP. 2010. Kir 2. 1 channelopathies: the Andersen-Tawil syndrome. Pflugers Arch. 460:289-944
142. Ueda K, Valdivia C, Medeiros-Domingo A, Tester DJ, Vatta M, et al. 2008. Syntrophin mutation associated with long QT syndrome through activation of the nNOS-SCN5A macromolecular complex. Proc. Natl. Acad. Sci. USA 105:9355-600
143. Valdivia CR, Ueda K, Ackerman MJ, Makielski JC. 2009. GPD1L links redox state to cardiac excitability by PKC-dependent phosphorylation of the sodium channel SCN5A. Am. J. Physiol. Heart Circ. Physiol. 297:H1446-522
144. van der Werf C, Kannankeril PJ, Sacher F, Krahn AD, Viskin S, et al. 2011. Flecainide therapy reduces exerciseinduced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia. J. Am. Coll. Cardiol. 57:2244-544
145. Vatta M, Ackerman MJ, Ye B, Makielski JC, Ughanze EE, et al. 2006. Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome. Circulation 114:2104-122
146. Veeramah KR, O'Brien JE, Meisler MH, Cheng X, Dib-Hajj SD, et al. 2012. De novo pathogenic SCN8A mutation identified by whole-genome sequencing of a family quartet affected by infantile epileptic encephalopathy and SUDEP. Am. J. Hum. Genet. 90:502-100
147. Vincent A, Lang B, Kleopa KA. 2006. Autoimmune channelopathies and related neurological disorders. Neuron 52:123-388
148. Wallace RH, Wang DW, Singh R, Scheffer IE, George AL Jr, et al. 1998. Febrile seizures and generalized epilepsy associated with amutation in theNa+-channel beta1 subunit gene SCN1B. Nat. Genet. 19:366-700
149. Wang JL, Cao L, Li XH, Hu ZM, Li JD, et al. 2011. Identification of PRRT2 as the causative gene of paroxysmal kinesigenic dyskinesias. Brain 134:3493-35011
150. Watanabe H, Chopra N, Laver D, Hwang HS, Davies SS, et al. 2009. Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans. Nat. Med. 15:380-833
151. Weaving LS, Christodoulou J, Williamson SL, Friend KL, McKenzie OL, et al. 2004. Mutations of CDKL55 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation. Am. J. Hum. Genet. 75:1079-933
152. Weber YG, Storch A, Wuttke TV, Brockmann K, Kempfle J, et al. 2008. GLUT1 mutations are a cause of paroxysmal exertion-induced dyskinesias and induce hemolytic anemia by a cation leak. J. Clin. Investig. 118:2157-688
153. Weiss J, Pyrski M, Jacobi E, Bufe B, Willnecker V, et al. 2011. Loss-of-function mutations in sodium channel Nav1. 7 cause anosmia. Nature 472:186-900
154. Xu Y, Padiath QS, Shapiro RE, Jones CR, Wu SC, et al. 2005. Functional consequences of a CKIdeltamutation causing familial advanced sleep phase syndrome. Nature 434:640-444
155. Yang Y, Wang Y, Li S, Xu Z, Li H, et al. 2004. Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia. J. Med. Genet. 41:171-744
156. Yu FH, Mantegazza M, Westenbroek RE, Robbins CA, Kalume F, et al. 2006. Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy. Nat. Neurosci. 9:1142-499
157. Zhang L, Jones CR, Ptícek LJ, Fu YH. 2011. The genetics of the human circadian clock. Adv. Genet. 74: 231-477
158. Zhou YD, Lee S, Jin Z, Wright M, Smith SE, Anderson MP. 2009. Arrested maturation of excitatory synapses in autosomal dominant lateral temporal lobe epilepsy. Nat. Med. 15:1208-144
159. Zhou YD, Zhang D, Ozkaynak E, Wang X, Kasper EM, et al. 2012. Epilepsy gene LGI1 regulates postnatal developmental remodeling of retinogeniculate synapses. J. Neurosci. 32:903-100
160. Zimprich A, Grabowski M, Asmus F, Naumann M, Berg D, et al. 2001. Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome. Nat. Genet. 29:66-699